132 related articles for article (PubMed ID: 15259283)
1. A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment.
Conner P; Christow A; Kersemaekers W; Söderqvist G; Skoog L; Carlström K; Tani E; Mol-Arts M; von Schoultz B
Climacteric; 2004 Mar; 7(1):50-8. PubMed ID: 15259283
[TBL] [Abstract][Full Text] [Related]
2. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
Lundström E; Hirschberg AL; Söderqvist G
Maturitas; 2011 Dec; 70(4):361-4. PubMed ID: 21958943
[TBL] [Abstract][Full Text] [Related]
3. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology.
Conner P; Söderqvist G; Skoog L; Gräser T; Walter F; Tani E; Carlström K; von Schoultz B
Breast Cancer Res Treat; 2003 Mar; 78(2):159-65. PubMed ID: 12725416
[TBL] [Abstract][Full Text] [Related]
4. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
[TBL] [Abstract][Full Text] [Related]
5. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
Lundström E; Christow A; Kersemaekers W; Svane G; Azavedo E; Söderqvist G; Mol-Arts M; Barkfeldt J; von Schoultz B
Am J Obstet Gynecol; 2002 Apr; 186(4):717-22. PubMed ID: 11967497
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy.
Nahas-Neto J; Luca LA; Griva BL; Morceli J; Nahas EA; Moriguchi SM; Uemura G; Traiman P
Maturitas; 2006 Jan; 53(1):97-106. PubMed ID: 15941630
[TBL] [Abstract][Full Text] [Related]
7. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women.
Sieuwerts AM; De Napoli G; van Galen A; Kloosterboer HJ; de Weerd V; Zhang H; Martens JW; Foekens JA; De Geyter C
Mol Oncol; 2011 Dec; 5(6):504-16. PubMed ID: 21956102
[TBL] [Abstract][Full Text] [Related]
9. Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism.
Manassiev N; Godsland IF; Proudler AJ; Whitehead MI; Stevenson JC
Clin Endocrinol (Oxf); 2013 Feb; 78(2):297-302. PubMed ID: 22775481
[TBL] [Abstract][Full Text] [Related]
10. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
11. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
Hofling M; Hirschberg AL; Skoog L; Tani E; Hägerström T; von Schoultz B
Menopause; 2007; 14(2):183-90. PubMed ID: 17108847
[TBL] [Abstract][Full Text] [Related]
12. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
13. Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.
Kotecha PT; Godsland IF; Crook D; Stevenson JC
Clin Endocrinol (Oxf); 2020 Apr; 92(4):303-311. PubMed ID: 31925799
[TBL] [Abstract][Full Text] [Related]
14. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
Hammar ML; van de Weijer P; Franke HR; Pornel B; von Mauw EM; Nijland EA;
BJOG; 2007 Dec; 114(12):1522-9. PubMed ID: 17995496
[TBL] [Abstract][Full Text] [Related]
15. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
Eilertsen AL; Karssemeijer N; Skaane P; Qvigstad E; Sandset PM
BJOG; 2008 May; 115(6):773-9. PubMed ID: 18355366
[TBL] [Abstract][Full Text] [Related]
17. Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women.
Cheng G; Butler R; Warner M; Gustafsson JÅ; Wilczek B; Landgren BM
Menopause; 2013 May; 20(5):496-503. PubMed ID: 23615640
[TBL] [Abstract][Full Text] [Related]
18. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Menopause; 1999; 6(4):299-306. PubMed ID: 10614676
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
Stuedal A; Ma H; Bjørndal H; Ursin G
Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
[TBL] [Abstract][Full Text] [Related]
20. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC
Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
